Combined Antibody Screening for Celiac and Diabetes Evaluation

Status unconfirmed

Conditions studied: Type 1 Diabetes, Celiac Disease

In brief

The CASCADE Study (Combined Antibody Screening for Celiac and Diabetes Evaluation) is an observational study whose primary goal is to show that population-based screening for advanced prediction of type 1 diabetes (T1D) and celiac disease (CD) is feasible to prevent diabetic ketoacidosis (DKA), improve celiac disease diagnosis, and ultimately gain public health acceptance to facilitate future prevention. It has two arms, a Birth Cohort and a Kids (cross sectional) Cohort.

Key facts

Study ID

NCT04677699

Run by

Pacific Northwest Research Institute

People needed

64410

Starts

2020-12-01

Expected to finish

2026-06-01

Last updated by the study team

2020-12-21

Who can join

Age: 0 and older, up to 7. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Child must be between 0 to 8 months in age or between 4 to 7 years in age. Child must be born in the state of Washington.

Where it is running

• Pacific Northwest Research Institute — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.